ro13-9904 and Brugada-Syndrome

ro13-9904 has been researched along with Brugada-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for ro13-9904 and Brugada-Syndrome

Article	Year
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab. International journal of dermatology, 2020, Volume: 59, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Betacoronavirus; Brugada Syndrome; Ceftriaxone; Clinical Laboratory Techniques; Continuous Positive Airway Pressure; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Male; Middle Aged; Nasopharynx; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2; Treatment Outcome	2020

Article

Year

Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.

International journal of dermatology, 2020, Volume: 59, Issue:8

Topics: Antibodies, Monoclonal, Humanized; Betacoronavirus; Brugada Syndrome; Ceftriaxone; Clinical Laboratory Techniques; Continuous Positive Airway Pressure; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Male; Middle Aged; Nasopharynx; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2; Treatment Outcome

2020